Skanray collaborates with Tata Elxsi to transform surgical imaging & medical technology

New Delhi: Skanray has announced a strategic partnership with Tata Elxsi to drive advancements in surgical imaging and healthcare technology through a comprehensive software platform and core technology development.

The partnership will focus on enhancing Skanray’s capabilities in diagnostic imaging by integrating Tata Elxsi’s expertise in software platform development and digital technologies. This new initiative seeks to transform the landscape of medical technology by creating modular, advanced, and affordable diagnostic systems.

Skanray is expanding its portfolio with new device families and modalities, including the development of an advanced analytics cloud platform. Tata Elxsi will lead the development of a software platform that supports all imaging, critical care, and surgical systems from Skanray. This platform is designed to ensure interoperability, compatibility, and multi-modal functionality, integrating the latest advancements in AI and Generative AI (GenAI).

Pankaj Madhukar Wani, Head of the Healthcare Business Unit at Tata Elxsi, highlighted,“The diagnostic imaging landscape is being transformed by software and digital technologies such as cloud and AI. We are delighted to be supporting Skanray in realising their long-term strategy and vision for healthcare. This long-term partnership will help create transformative solutions for healthcare facilities and patients worldwide.”

Priyanka Chatterjee, VP of Corporate Communications at Skanray Technologies Ltd., added, “By combining Skanray’s core technology and deep understanding of medical applications with Tata Elxsi’s capabilities in futuristic technology, we are poised to drive significant advancements in healthcare delivery. Our collaborative efforts will result in solutions that are not only technologically advanced, but are also operator-friendly, and cost-effective, helping healthcare providers deliver significantly improved health outcomes for patients.”